| Literature DB >> 29560726 |
Takeshi Yamada1,2, Miu Yagita2, Yutaka Kobayashi2, Goh Sennari2, Hiroyuki Shimamura2, Hidehito Matsui1, Yuki Horimatsu2, Hideaki Hanaki1, Tomoyasu Hirose1,2, Satoshi O Mura1, Toshiaki Sunazuka1,2.
Abstract
Total synthesis of bottromycin A2 can be accomplished through a diastereoselective Mannich reaction of a chiral sulfinamide, mercury-mediated intermolecular amidination, and cyclization of a constrained tetracyclic peptide. Exploitation of this process allowed the synthesis of several novel bottromycin analogs. The antimicrobial activity of these analogs was evaluated in vitro against Gram-positive bacteria, such as methicillin resistant Staphylococcus aureus (MRSA) and vancomycin resistant enterococci (VRE). Structure-activity relationships were explored taking into consideration the unique three-dimensional structure of the compounds. Notably, one of the new analogs devoid of a methyl ester, which is known to lower the in vivo efficacy of bottromycin, exhibited antibacterial bioactivity comparable to that of vancomycin.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29560726 DOI: 10.1021/acs.joc.8b00045
Source DB: PubMed Journal: J Org Chem ISSN: 0022-3263 Impact factor: 4.354